• Info
  • Insider Ownership

Insider Trading & Ownership of Keith Katkin

Location
Irvine, CA
Summary
The estimated net worth of Keith Katkin is at least $1,499,465 dollars as of 28 May 2025. Keith Katkin is the Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $911,200. Keith Katkin is the Director of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $544,515. Keith Katkin is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $43,750.
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Keith Katkin files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Keith Katkin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc Director $911,200 +$91,120 +11% 19 May 2025
EBS Emergent BioSolutions Inc. Director $544,515 -$49,417 -8.3% 23 May 2025
RIGL RIGEL PHARMACEUTICALS INC Director $43,750 19 May 2021
ELDN Eledon Pharmaceuticals, Inc. Director 10 Jan 2025

Insider Transactions Reported by Keith Katkin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.